New hires:
Voyager Therapeutics named Toby Ferguson as chief medical officer.
Apellis Pharmaceuticals executive Ramiro Ribeiro is joining EyePoint Pharmaceuticals as chief medical officer.
Specialist biometrics clinical research organization Veramed appointed Karen Curran as Chief Strategy Officer.
MultiPlan named Jerry Hogge as chief operating officer.
Biotech FibroBiologics appointed Ruben Garcia as general counsel.
Houlihan Lokey announced Brent Shepherd will co-lead the firm’s healthcare capital markets efforts alongside Managing Director Neha Shah.
Healthcare investment firm Sofinnova Investments tapped Troy Ignelzi as executive advisor.
StimScience named former FitBit chief marketing officer Tim Rosa as its CEO.
Executive elevations:
Tim Clackson, former Theseus CEO, is succeeding Ben Auspitz as CEO. Theseus CFO Brad Dahms will also add the title of business chief.
Life sciences agency Ramarketing promoted a pair of leaders.
Board appointments:
Gossamer Bio added Dr. Steven D. Nathan and Skye Drynan to its board of directors.
CRISPR Therapeutics proposed Christian Rommel, PhD to join its board of directors.
Veru named Louis Aronne, MD, as chief medical advisor and a member of its scientific advisory board.
Atossa Therapeutics appointed breast cancer specialist Tessa Cigler to its board of directors, effective immediately.
Therabody formalized its scientific advisory board, invested more than $10 million to support initiatives aimed at innovating and scientifically validating its products and partnered with the American College of Sports Medicine.
Nimbus Therapeutics named Katharine Knobil, MD, to its board of directors.
Health tech company Spatially Health appointed Leigh Ann Ruggles to its advisory board.
Departures:
BioNTech announced that chief business and commercial officer Sean Marett will retire and continue as a specialist advisor at least until the end of the year. The German drugmaker said it plans to name a new chief commercial officer by the end of the month.
Additionally, his responsibilities as chief business officer are being gradually transferred to chief legal officer James Ryan, PhD.
Clinical-stage biopharma Pulmatrix announced the termination of its chief medical officer Dr. Margaret Wasilewski as it moves to an outsourced model.
